Comera Investor Presentation Deck

Ongoing Revenue-Generating, with Additional Collaborations on the Horizon ● ● ● ● Partnership #1 Regeneron Leading US biotechnology company High-priority assets in development Recently extended and broadened Includes a right to negotiate license after further technical evaluation complete ● High-Value Partnerships, Ⓡ Current Partnerships Partnership #2 Undisclosed Top 10 global pharma company Drug commercialized globally, currently the largest biologic drug by revenue to Company (top two overall) Option to license after further technical evaluation complete ● (< Comera LIFE SCIENCES Partnership #3 Intas Pharmaceuticals Ltd. Intas Pharmaceuticals is a leading, vertically- integrated pharmaceutical company. Development of a biosimilar product in oncology Option to license after further technical evaluation 17

View entire presentation